<< Back to Results
A Phase 1b/2 Randomized Phase 2 Study Evaluating the Efficacy of Doxorubicin With or Without a Human Anti-PDGFRa Monoclonal Antibody (IMC-3G3) in the Treatment of Advanced Soft Tissue Sarcoma
- Objective
- Not available at this time
- IRB Protocol Number
- 10-1261
- Principal Investigator(s)
- ANTHONY ELIAS
-
- Sponsor(s)
- Contact
- TESSA MCSPADDEN at 720-848-0609
or TESSA.MCSPADDEN@UCDENVER.EDU
- Eligibility and Other Participant Information
- What To Expect : Not available at this time // Not available at this time